RACHEL WALSH: Open Payments
NPI 1891746582 · PHILA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,123 in 93 payments from 18 companies in 2025. Trend: 2023 $1,900 · 2024 $1,912 · 2025 $2,123
Food & beverage: $2,123
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $311 |
| JAZZ PHARMACEUTICALS INC. | 7 | $257 |
| GlaxoSmithKline, LLC. | 16 | $252 |
| Regeneron Healthcare Solutions, Inc. | 7 | $197 |
| Actelion Pharmaceuticals US, Inc. | 11 | $188 |
| Verona Pharma, Inc. | 6 | $170 |
| Grifols USA, LLC | 4 | $126 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $102 |
| ANI Pharmaceuticals, Inc. | 3 | $80 |
| Philips North America LLC | 4 | $73 |
Products named: XYWAV, DUPIXENT, TRELEGY ELLIPTA, Ohtuvayre, Prolastin-C Liquid, TEZSPIRE, AIRSUPRA, OPSUMIT.
Industry payments across PA — which companies pay providers there.
